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Abstract
Background: We demonstrated that E2 conjugated to BSA (E2BSA) induces a rapid membrane-initiated inhibition of 
LH secretion followed hours later by a slight increase in LH secretion. Whether these actions of E2BSA are restricted to 
the pituitary gland and whether the membrane-initiated pathway of E2BSA contributes to the up-regulation of the 
number of GnRH receptors during the positive feedback effect of E2 were evaluated here. We have shown that the 
suppression of LH secretion induced by E2 and E2BSA is the result of a decreased responsiveness of the pituitary gland 
to GnRH. In this study we further tested the ability of E2BSA to decrease the responsiveness of the pituitary gland to 
GnRH under the paradigm of the preovulatory surge of LH induced by E2.
Methods: For the first experiment GnRH and LH secretions were determined in samples of pituitary portal and jugular 
blood, respectively, in ewes treated with 12 mg E2BSA. In the second experiment, the number of GnRH receptors was 
quantified in ewes 12 h after administration of 25 micrograms E2 (the expected time for the increase in the number of 
GnRH receptors and the positive feedback effect of E2 in LH secretion) or 12 mg E2BSA. In the third experiment, the 
preovulatory-like surge of LH was characterized in ewes injected with 25 micrograms E2 alone or followed 8 h later 
(before the beginning of the LH surge) with 60 mg E2BSA.
Results: a) the decrease in LH secretion induced by E2BSA was not accompanied by changes in the pulsatile pattern of 
GnRH, b) E2BSA increased the number of GnRH receptors, and c) the presence of E2BSA in E2-treated ewes delayed the 
onset, reduced the length, and decreased the amount of LH released during the preovulatory surge of LH.
Conclusions: a) the rapid suppression of LH secretion induced by E2BSA is mediated only via a direct action on the 
pituitary gland, b) E2 acting via a membrane-initiated pathway contributes to increase the number of GnRH receptors 
and, c) administration of E2BSA near the beginning of the pre-ovulatory surge of LH delays and reduces the magnitude 
of the surge.
Background
The ability of E2 to induce a preovulatory surge of LH [1-
5] is the result of actions of E2 on both the pituitary gland
and the hypothalamus. In the pituitary gland E2 increases
the sensitivity to GnRH by inducing synthesis of GnRH
receptors on gonadotropes [6,7]. In the hypothalamus E2
induces a sustained surge of GnRH [5,8]; possibly by acti-
vating E2-receptive neurons that in turn activate GnRH
neurons [9,10]. Two decades ago, evidence for a short-
term negative feedback of E2 on secretion of LH was
reported [2,11]. From studies in a variety of endocrine
paradigms it has been shown that both the pituitary gland
[2,12-14] and the hypothalamus mediate the rapid inhibi-
tion of LH by E2 [5,15-18] and that the transition from
negative to positive feedback in the pituitary gland is an
important component for onset of the preovulatory surge
of LH [19].
The ability of E2 to modulate cellular function via novel
membrane-initiated (non-genomic) mechanisms [20-23]
opens new avenues to study a potential interaction
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between positive and negative feedback effects of E2 on
secretion of LH. E2 conjugated to BSA has been used
widely to mimic non-genomic biological responses of E2
in a variety of tissues [24-29]. The rapid biological
responses induced by E2BSA are interpreted to be as an
action initiated at the cell membrane, acting through spe-
cific binding sites that are linked to intracellular signal
transduction proteins.
W e  p r e v i o u s l y  d e m o n s t r a t e d  t h a t  e i t h e r  f r e e  E 2  or
E2BSA induced a rapid decrease in secretion of LH in
OVX ewes [30] and in primary cultures of pituitary cells
[13], suggesting a direct action on the pituitary. In the
current study, we conducted experiments to examine if
membrane-initiated actions of E2-BSA in regulating LH
secretion were restricted to the level of the pituitary
gland. In the first experiment we tested the hypothesis
that E2BSA would rapidly inhibit pulsatile secretion of LH
without a corresponding decrease in GnRH release from
the hypothalamus.
Genomic and non-genomic actions of E2  frequently
converge to induce the same cellular response [20-23].
Under this comprehensive model, E2  binds to both
nuclear receptors and to putative plasma membrane
binding sites. Binding of E2 to nuclear receptors leads to
an interaction with estrogen response elements (ERE) in
target genes resulting in regulation of gene transcription.
In contrast, binding of E2 to membrane binding sites acti-
vates specific signal transduction pathways resulting in a
more efficient up- or down-regulation of gene transcrip-
tion. We previously reported that conjugated forms of E2
did not induce a preovulatory-like surge of LH; instead a
slight but significant increase in serum concentrations of
LH was detected at the expected time of the massive
release of LH [30]. Since it is unlikely that a molecule as
large as E2BSA crosses the blood-brain barrier to induce a
preovulatory-like surge of GnRH, we speculated that the
slight increase in secretion of LH is the result of a direct
action on the pituitary gland to increase the number of
GnRH receptors [30]. In the second experiment of this
study, we examined the hypothesis that E2BSA will
increase the number of GnRH receptors in OVX ewes.
The ability of conjugated E2 to diminish the responsive-
ness of the pituitary gland to GnRH has been demon-
strated in primary cultures of ovine pituitary cells [13].
The third experiment described herein further evaluates
the ability of E2BSA to override the massive release of LH
induced by a single bolus of free E2. The hypothesis is that
E2BSA by acting at the plasma membrane level could
diminish the responsiveness of the pituitary gland during
the surge of GnRH induced by E2.
Methods
Preparation of media and stock solution
Free E2 was removed from E2BSA (Steraloids Inc., New-
port, RI) by ten consecutive extractions with diethyl ether
[31]. As previously shown [13], less than 1% of the weight
of the conjugate was removed as free E2, and the amount
of free E2 remaining in the E2BSA conjugate was substan-
tially less than the concentration needed to elicit a physi-
ological response. D-Ala6-desGlyNH2
10-GnRH-
ethylamide (D-Ala6-GnRH-EA) and E2 were purchased
from Sigma (Sigma-Aldrich, Inc., Saint Louis, MO). E2
was freshly dissolved in ethanol the day of treatment and
emulsified in mineral oil, whereas E2BSA was dissolved in
sterile saline solution.
Stability of E2BSA in serum
A caveat of using E2BSA as a tool to study non-genomic
actions is the potential instability of the conjugate. Our
assumption was that if the conjugate breaks down, the
resulting free (non-conjugated) E2 should be detectable in
serum after organic solvent extraction. Therefore, to eval-
uate the ability of E2BSA to remain conjugated in serum,
OVX ewes (n = 3) received 174 nmoles E2BSA (based on
the molecular weight of BSA) or 92 nmoles of E2 intra-
muscularly. This dose of E2BSA induces a rapid suppres-
sion of LH secretion; followed by a preovulatory-like
surge of LH [30]. Blood samples were collected at 0, 1, 2,
6, 10, 16, and 24 h after treatment. Non-conjugated E2
was removed from serum samples by two consecutive
extractions with diethyl ether and immunoreactive E2 was
quantified by RIA [31]. The intra-assay coefficient of vari-
ation was 12% and the assay sensitivity was 0.18 pg/per
tube.
Measurement of GnRH receptors
GnRH receptors were quantified as previously described
[32]. The pituitary gland was divided mid-sagitally and
half of the anterior pituitary was homogenized (100 mg/
ml) in Tris buffer (10 mM Tris, 1 mM CaCl2, and 0.1% [w/
v] bovine serum albumin [pH = 7.4]). The homogenate
was centrifuged at 30,000 × g for 30 min at 4 C and super-
natant was decanted. The top two layers of the pellet were
resuspended in 5 ml of Tris buffer and rehomogenized in
a Dounce homogenizer. The tissue was centrifuged at
30,000 × g for 30 min at 4 C and the top layer of the pellet
was removed and resuspended in 1 ml of Tris buffer. Pro-
tein concentration was determined using the BCA pro-
tein assay kit (Pierce, Rockford, IL). [125I]-D-Ala6-GnRH-
EA was prepared by the glucose oxidase-lactoperoxidase
technique [33]. Fifty and 100 μl of crude membrane prep-
arations were incubated with 0.43 nM [125I]-D-Ala6-Arreguin-Arevalo et al. Reproductive Biology and Endocrinology 2010, 8:40
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GnRH-EA in a total volume of 150 μl for 4 h at 4 C. At the
end of the incubation, the membranes were diluted with 3
ml of ice-cold Tris buffer and centrifuged for 10 min at
30,000 × g. The supernatants were decanted and the
radioactivity remaining in the pellet was quantified.
Number of GnRH receptors were quantified using a stan-
dard curve technique as described previously [32]. All
samples were quantified in one assay and the inter-assay
coefficient of variation was 2.8%.
Animals and experimental protocol
Procedures involving animals in experiment 1 were
approved by the Committee for the Use and Care of Ani-
mals at the University of Michigan whereas procedures in
experiments 2 and 3 were approved by the Colorado State
University Animal Care and Use Committee and com-
plied with National Institutes of Health (NIH) guidelines.
All experiments were carried out between October and
January (breeding season) and ewes were ovariectomized
(OVX) at least 2 months before treatment. In a prelimi-
nary experiment a single im bolus of E 2BSA induced a
decrease in secretion of LH followed by a slight rise in
serum concentrations of LH. Therefore steroids were
administered intramuscularly.
Experiment 1
Mature Suffolk ewes (n = 6) were fitted with an apparatus
for collection of pituitary portal blood, according to pro-
cedures described previously [34]. After a 2-wk recovery
period, ewes were equipped with two indwelling jugular
catheters, one for collecting peripheral blood and one for
infusing heparin saline (250 U/min). Samples of pituitary
portal and jugular blood were collected through a remote
automated sampling system that allows continuous col-
lection of samples [34]. Pituitary portal and jugular blood
samples were withdrawn continuously and separated into
10-min fractions for analysis of GnRH [35] and LH [36]
by radioimmunoassay. GnRH quantification was carried
out at University of Michigan whereas LH was quantified
at Colorado State University. Pituitary portal blood was
dispensed into tubes containing ice-cold bacitracin,
extracted with methanol (~300 μl plasma) within 1.5 h of
sampling and stored at -80 C until analysis of GnRH.
After sample collection, ewes were euthanized and the
pituitary was inspected for appropriate placement of the
lesion in the portal vasculature, to corroborate adequate
collection of pituitary portal blood. One ewe (data not
shown) was excluded since there was not an obvious
l e s i o n  o n  t h e  p i t u i t a r y  g l a n d  a n d  G n R H  v a l u e s  w e r e
exceedingly low and not clearly episodic. For GnRH the
intra-assay coefficient of variation was 4.3% and the assay
sensitivity was 0.09 pg/tube (3 assays). For LH the intra-
assay coefficient of variation was 5% and the assay sensi-
tivity was 30 pg/tube. To evaluate the ability of E2BSA to
suppress the pulsatile pattern of GnRH, six ewes received
12 mg E2BSA intramuscularly. Pituitary portal and
peripheral blood were separated into 10 min fractions
from 4 h before to 4 h after treatment with E2BSA. GnRH
and LH pulses were defined as an increase in hormone
concentration higher than the mean concentration
detected during the 4 h pre-treatment period within an
individual followed by at least one descending hormone
concentration. GnRH and LH pulse amplitudes were
defined as the difference between the peak and its pre-
ceding nadir. Because the sampling procedure measures
GnRH only in its initial pass through the portal system
(GnRH re-circulating from periphery is undetectable)
and because many GnRH pulses were split between two
consecutive 10-min samples [GnRH pulses last 5-6 min
[37]], the amplitude of a given GnRH pulse was calculated
by adding all values greater than baseline and subtracting
the value of the preceding nadir. GnRH in pituitary portal
blood was calculated as a collection rate (pg per minute)
rather than concentration. This minimizes error due to
changes in rate of portal blood withdrawal caused by
changes in head position or contamination of portal
blood with CSF (cerebrospinal fluid) or peripheral blood.
The latter was judged to be minimal based on little or no
blood aspirated into the sampling lines during the hour
prior to lesion of the portal vessels; CSF contamination
was negligible based on hourly hematocrit measures dur-
ing sampling.
Experiment 2
Mature Western-range ewes were fitted with a jugular
cannula to withdraw blood samples. To determine if an
increase in the number of GnRH receptors was associ-
ated with the increase in LH induced by E2BSA, ewes (n =
6) received 92 nmoles E2 (in 3 ml of safflower oil) or 174
nmoles E2BSA (in 3 ml saline solution). Sham injections
of saline solution or safflower oil were administrated to
E2- and E2BSA-treated ewes, respectively. This dose of
E2BSA induces a slight but significant increase in serum
concentrations of LH at the expected time of the massive
release of LH [30,38]. Blood samples were collected
before administration of estrogenic compounds and
every 2 h from 6 to 12 h after treatment. To minimize the
effect of GnRH released during a preovulatory-like surge
of LH on the number of GnRH receptors, pituitary glands
were collected at the beginning of the time of the
expected surge of LH (12 h after treatment). This interval
proved to be sufficient to induce the highest number of
GnRH receptors in primary cultures of ovine pituitary
cells incubated with E2 or E2BSA [39]. Concentrations of
LH were determined in one assay. The intra-assay coeffi-
cient of variation was 5% and the assay sensitivity was 36
pg/tube.Arreguin-Arevalo et al. Reproductive Biology and Endocrinology 2010, 8:40
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Experiment 3
The objective was to test the hypothesis that E2BSA is
able to disrupt the preovulatory-like surge of LH induced
by E2. Disruption of the preovulatory-like surge of LH
would open a new avenue to study conjugated forms of E2
as a potential method of contraception that might be
more specific than the current steroidal contraceptives.
We have demonstrated that conjugated E2  is able to
reduce GnRH-induced release of LH in primary cultures
of ovine pituitary cells [13] and to suppress pulsatile
secretion of LH in OVX ewes for at least 10 h under basal
secretion of GnRH [30]. W e speculated that E 2BSA, by
acting at the plasma membrane level, could diminish the
responsiveness of the pituitary gland to the surge of
GnRH induced by E2. We presumed that, in order to
overcome the stimulatory effect of the massive release of
GnRH, a higher dose of E2BSA would be necessary. Thus,
we administered E2BSA to a dose ~10 times higher than
E2 (based on molecular weight of BSA). Due to the vari-
ability in the magnitude of LH surge induced by E2, in a
preliminary study the magnitude of the LH surge was
determined in mature Western-range ewes. Animals
were ranked based on the mean LH during the surge and
t h e n  a s s i g n e d  t o  e i t h e r  a  h i g h  o r  a  l o w  E 2-responsive
group (n = 6 per group). At least one month later, ewes (n
= 12) ranked within each E2-responsive group were alter-
nately assigned to received an im injection of 92 nmoles
E2 at time zero. Six of these ewes received an im injection
of 870 nmoles E2BSA (in 3 ml saline solution) or saline
solution 8 h after injection of E2. Blood samples were col-
lected every hour from 4 h before to 28 h after treatment
and LH was quantified. Intra- and inter-assay (10 assays)
coefficients of variation for LH were 5 and 10%, respec-
tively. The assay sensitivity was 32 pg/tube. The effect of
E2 alone or together with E2BSA on the preovulatory-like
surge of LH was evaluated using five parameters: 1) Mean
LH, 2) Amplitude; defined as the highest concentration of
LH, 3) Area under the curve during the surge of LH
(AUC), 4) Length of the preovulatory-like surge, defined
as the period between the onset and the end of the LH
surge, and 5) Interval from administration of E 2 to the
onset of the massive release of LH. A preovulatory-like
surge of LH was described as a concentration of LH equal
to or higher than the pre-treatment mean LH plus 2 stan-
dard deviations detected within an individual (surge
onset), followed by increasing concentrations of LH
reaching an amplitude of at least 40 ng/ml, and remaining
over onset concentration for at least 6 h. The end of a
surge of LH was described as a descending concentration
of LH, equal to or lower than the pre-treatment mean LH
plus 2 standard deviations detected within an individual.
A preovulatory-like surge of LH was defined as the
period during which an increasing concentration of LH
equal to or higher than the pre-treatment mean LH plus 2
standard deviations first is detected within an individual,
reaching amplitude of at least 40 ng/ml, and remaining
over onset concentration for at least 6 h. The end of a
surge of LH was defined as a descending concentration of
LH that no longer met the criteria for a surge.
Data analysis
Data were subjected to analysis of variance (ANOVA)
using the general linear model of SAS [40]. Serum con-
centrations of LH (experiments 1 and 2) and E2, as well as
GnRH collection rate (experiment 1) were evaluated by
repeated measures analysis. Number of pulses of GnRH
and LH were subjected to arcsine transformation.
Changes in the number of GnRH receptors were analyzed
in a completely randomized design. Variables related to
the preovulatory-like surge of LH (experiment 3) were
analyzed in a completely randomized design with a facto-
rial arrangement. The factors included in the analysis
were treatment, level of responsiveness to E2 (high and
low) and their interaction. When differences among
treatment means were detected, they were separated
using the Least Significant Difference (LSD) procedure. If
variances were not homogeneous, data were Log10 trans-
formed.
Results
To demonstrate the stability of E2BSA in serum, ewes
received an im injection of either E2 (92 nmoles) or E2BSA
(174 nmoles) and free, unconjugated E2 was quantified. In
E2-treated ewes serum concentrations of E2 reached a
peak (P < 0.01; 206 ± 15 pg/ml) 1 h after administration,
remained above baseline for at least 16 h and then
returned to pre-treatment concentration (1.0 ± 0.3 pg/
ml). Conversely, in E2BSA-treated ewes there was no
change in serum concentrations of immunoreactive E2
and it remained similar to pre-treatment levels during the
period evaluated (0.7 ± 0.3 vs. 1.0 ± 0.3 pg/ml).
Experiment 1
GnRH and LH profiles of individual ewes treated with
E2BSA are depicted in Figure 1a. Prior to treatment,
GnRH and LH pulses were readily detected in all ewes. In
4 of 5 ewes, LH pulses were less evident after administra-
tion of E2BSA. In the remaining ewe (# 3), LH decreased
steadily during the post-E2BSA period. Compared to pre-
treatment period (Figure 1b), E2BSA decreased mean
plasma concentrations of LH (P < 0.02) and the number
of pulses of LH (P < 0.01); however, no changes were
detected in the amplitude of pulses of LH. In contrast to
LH, E2BSA did not alter the mean collection rate ofArreguin-Arevalo et al. Reproductive Biology and Endocrinology 2010, 8:40
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Figure 1 Effect of E2BSA on the secretory patterns of LH and GnRH. (a) Secretory patterns of LH and GnRH in individual ewes during the acute 
inhibition of LH induced by E2BSA. Patterns of LH (open diamonds) and GnRH (closed squares) in individual ewes treated with an im bolus of 12 mg 
E2BSA (hour 0). GnRH and LH were measured in samples of pituitary portal and jugular blood, respectively, withdrawn continuously and separated 
into 10-min fractions, from 4 h before to 4 h after treatment. (*) is indicative of a pulse. (b) E2BSA decreased secretion of LH without affecting the se-
cretory patterns of GnRH during the acute inhibition of LH secretion. Mean plasma rate of GnRH, number of pulses of GnRH and amplitude of pulses 
(right panel) were measured in pituitary portal blood whereas mean LH, number of pulses and amplitude of pulses of LH (left panel) were measured 
in jugular blood. Samples were collected at 10-min intervals, from 4 h before (open bars) to 4 h after treatment (solid bars). Data are presented as the 
mean ± SEM. Comparisons were made within periods. a, b differ (P < 0.02); c, d differ (P < 0.01).
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GnRH, the number of pulses of GnRH, or the amplitude
of pulses of GnRH (Figures 1a and 1b).
Experiment 2
Twelve hours after treatment with E2 or E2BSA the num-
ber of GnRH receptors increased (P < 0.05) compared to
controls (Figure 2 insert). The increase was higher (P <
0.05) in E2-treated ewes compared to ewes treated with
E2BSA (Figure 2 insert). Before treatments, serum con-
centrations of LH were similar among groups (Figure 2).
Twelve hours after administration of the estrogenic com-
pounds, serum concentrations of LH were elevated (P <
0.05) in E2- and E2BSA-treated ewes and were higher (P <
0.01) in ewes treated with E2 than in ewes treated with
E2BSA (Figure 2).
Experiment 3
Figure 3 depicts individual LH profiles during the preo-
vulatory-like surge of LH in OVX ewes treated with E2
alone and E2 followed 8 h later by E2BSA or saline solu-
tion. The panels on the left depict the LH profiles of ewes
previously classified as highly responsive to E2. The pan-
els on the right depict the LH profiles of ewes previously
Figure 2 E2 and E2BSA increased the number of GnRH receptors and LH secretion at the expected time for the beginning of the preovula-
tory-like surge of LH. Effect of Ewes (n = 6) received an im injection of saline solution (control), E2, or E2BSA at time zero. Mean serum LH was mea-
sured at 0, 6, 8, 10, and 12 h after treatments. Comparisons were made within and among treatments. a, b differ (P < 0.05), c differs from a/b (P < 0.01). 
Insert depicts changes in the number of GnRH receptors in ovine pituitary glands from ewes 12 h after administration of treatments. Bars with unlike 
subscripts differ (P < 0.05). Data are presented as the mean ± SEM.
a
c
bArreguin-Arevalo et al. Reproductive Biology and Endocrinology 2010, 8:40
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classified as less responsive to E2. All ewes treated with E2
expressed a surge of LH, starting approximately 12.1 h
(725 ± 34 min) after injection of E2 with an average length
of 11.4 h (685 ± 49 min; Figures 3 and 4a). Intramuscular
injection of 60 mg E2BSA in ewes pre-treated with E2
delayed (P < 0.05; Figure 4a) the onset of the preovula-
tory-like surge of LH and decreased (P < 0.05; Figure 4a)
the length and amplitude of the surge of LH regardless
the level of responsiveness to E2; E2BSA decreased mean
serum concentrations of LH and the AUC (i.e. the total
amount of LH released) only in ewes classified as highly
responsive to E2 (P < 0.05; Figure 4b).
Discussion
We demonstrated previously that equimolar concentra-
tions of free E2 or E2 conjugated to BSA suppressed the
Figure 3 Secretory pattern of LH in individual ewes showing the effect of a high dose of E2BSA on the preovulatory-like surge of LH induced 
by E2. In a preliminary study the magnitude of the LH surge in response to E2 was determined; ewes were ranked based in the mean LH during the 
surge induced by E2, then assigned to either a high (LH profiles in the left panel) or a low (LH profiles in the right panel) E2-responsive group (n = 6 
per group). Approximately one month later, ewes (n = 12) were given an im injection of 25 μg E2 and then assigned alternatively within each respon-
sive group, to receive an im injection of 60 mg E2BSA (open squares) 8 h after injection of E2 or saline solution (placebo; closed diamonds). The negative 
impact to E2BSA on the massive release of LH induced by E2 was more pronounced in ewes classified as highly responsive to E2.
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Figure 4 Effect of E2BSA on the preovulatory-like surge of LH induced by E2. Ewes received an im injection of 60 mg E2BSA 8 h after injection of 
E2 or saline solution (placebo). Data are presented as the mean ± SEM. Unlike subscripts differ (P < 0.05). (a) E2BSA delayed the interval to the surge, 
reduced the length of the surge, and decreased the amplitude of the surge induced by E2, regardless the magnitude of the response to E2. (b) E2BSA 
decreased the mean LH and the AUC (area under the curve of LH) induced by E2, but only in ewes classified as highly responsive to E2.
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GnRH-induced release of LH in cultures of ovine pitu-
itary cells [13] suggesting a direct action on the pituitary
gland. In OVX ewes, a similar decrease in LH secretion
was recapitulated by administration of E2 or E2BSA at
equimolar concentrations [30]. In this study we tested the
possibility that the decrease in LH secretion induced by
E2BSA could (at least partially) be mediated by an action
at the level of the hypothalamus. We found that the
decrease in LH pulse frequency and mean LH induced by
E2BSA was not accompanied by changes in either pulse
frequency or pulse amplitude of GnRH. Therefore, the
actions of E2BSA on LH secretion seem to occur only at
the level of the pituitary gland, presumably by decreasing
responsiveness to GnRH. Together with our previous
reports [13,30], these data suggest that pharmacological
targeting of the pituitary gland with E2BSA is sufficient to
mimic the rapid inhibitory action of E2 on LH secretion. It
is worth mentioning that we did not detect a decrease in
the pulse amplitude of LH. It is possible that our criterion
to detect pulses did not identify small increases in LH
concentrations as pulses, or that our sampling was too
infrequent to detect a marginal decrease in pulse ampli-
tude. The exclusion of these "low amplitude pulses" may
ha ve masked an effect on the amplitude of LH pulses.
Nevertheless, since E2BSA did not decrease either pulse
frequency or pulse amplitude of GnRH, the effect of
E2BSA on LH secretion is attributed to a direct action on
the pituitary gland. The apparent lack of effect of E2BSA
on the secretory pattern of GnRH provides evidence that
E2BSA does not have a hypothalamic effect, possibly
because it does not cross the blood-brain barrier. In a
recent study [41] evidence was provided for the mecha-
nism underlying the rapid inhibitory effect of E2 on the
GnRH-induced release of LH secretion in primary cul-
tures of ovine pituitary cells. In that study, the increase in
cytoplasmic intracellular free calcium concentration
([Ca++]i) mediating the GnRH-induced release of LH
secretion was abolished by 2 min pretreatment with E2 or
E2BSA, which agrees with the time frame for the begin-
ning of the rapid decrease of LH secretion induced by
estrogens. In hypothalamus-pituitary-disconnected ewes,
E2  increased the number of gonadotropes expressing
phosphorylated extracellular signal-regulated-kinases 1
and 2 (pERK-1/2), c-AMP-responsive element-binding
protein (pCREB), and serine 473 kinase (pAkt) within 15
to 90 minutes after administration of E2 [42]. Whether
these and/or other upstream signaling molecules contrib-
ute to maintain a decreased responsiveness of the pitu-
itary gland to GnRH (for at least 10 h in our previous
study [30]) after administration of estrogens is yet to be
evaluated.
A caveat of using E2BSA as a tool to study non-genomic
actions is the stability of the conjugate, particularly if the
conjugate is used in studies in vivo. We demonstrated
[30] that conjugated forms of E2 mimicked the acute non-
genomic action of E2 (i.e. rapid decrease of LH secretion),
but not the more prolonged, presumably genomic actions
(i.e. preovulatory-like surge of LH and decrease in FSH
secretion). These data strongly support the conclusion
that there is insufficient free E2 (i.e. enough to mimic the
genomic actions) in the conjugate to have a biological
effect. In the current study we provided further evidence
on the stability of E2BSA in blood. It is known that E2 can
rapidly regulate secretion of GnRH [8,16,18,43,44]. Con-
sequently, the fact that E2BSA did not change the secre-
tory pattern of GnRH strengthens our previous
conclusion of the absence of sufficient free E2 to induce a
physiological response. Furthermore, administration of
E2BSA to OVX ewes did not raise serum concentrations
of free E2 over pre-treatment levels during the 24 hours
evaluated. Therefore, the actions of E2BSA can only be
attributed to the conjugated form of E2.
In a previous report [30], we showed that infusion of
E2BSA to OVX ewes did not induce a typical preovula-
tory-like surge of LH; instead a slight but significant
increase in serum concentrations of LH was detected at
the time of the expected massive release of LH. The pos-
sibility that the slight increase in LH secretion induced by
E2BSA was the result of an increase in the number of
GnRH receptors was evaluated in this study. Indeed,
administration of E2BSA to OVX ewes increased the
number of GnRH receptors in the pituitary gland and it
was associated with a slight rise in serum concentrations
of LH at the expected time for the beginning of the preo-
vulatory-like surge of LH (12 h after administration of
conjugated E2). This report provides the first in vivo evi-
dence in ewes of a membrane-initiated pathway as a com-
ponent of the mechanisms underlying the synthesis of
GnRH receptors induced by E2. It seems that the non-
genomic actions of E2  in the pituitary gland are not
restricted to the rapid suppression of pulses of LH
reported elsewhere [13]. The ability of E2BSA to induce
both a suppression in responsiveness of the pituitary
gland to GnRH and an increase in the number of GnRH
receptors is compatible since E2 up-regulates the number
of GnRH receptors subsequent to the short-term negative
feedback [2,6,45,46] and the sum of these two events may
be part of the strategy to ensure a buildup of pituitary
content of LH for a robust preovulatory surge. Since an
ERE is not involved in mediating the actions of E2BSA
[24,27,47,48] and a canonical ERE has not been reported
in the GnRH receptor gene [47-50], we speculate that aArreguin-Arevalo et al. Reproductive Biology and Endocrinology 2010, 8:40
http://www.rbej.com/content/8/1/40
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membrane-initiated pathway may activate down-stream
events facilitating the transcription of GnRH receptors,
as well as inhibiting GnRH-induced secretion of LH. As
mentioned above, an increase in phosphorylation level of
a number of proteins in the gonadotropes has been
reported 15 to 90 minutes after administration of E2 [42].
The ability of E2 or E2BSA to increase the level of protein
phosphorylation for longer periods would be compatible
with our speculation on a membrane-initiated pathway as
a component in the synthesis of GnRH receptors number,
as well as maintaining the inhibition of LH secretion after
the initial decrease. The ability of E2 and E2BSA to acti-
vate upstream signaling molecules for longer intervals
has yet to be evaluated.
The ability of E2BSA to inhibit responsiveness of pri-
mary cultures of ovine pituitary cells to GnRH [13] was
the basis for examining its ability to abolish the E2-
induced massive release of LH in ewes. Based on our pre-
vious in vivo study [30] E2BSA would decrease respon-
siveness of the pituitary gland to GnRH within the first
hour after E2BSA, and it remained decreased for at least
10 h under basal secretion of GnRH. In the current exper-
iment we overlap the period of a decreased responsive-
ness of the pituitary gland to GnRH to the expected time
for the surge of LH by administering E2BSA 8 h after E2
(2-3 h before the beginning of the preovulatory-like surge
of LH) at a dose 10 times higher than previously reported
[30]. Under these experimental conditions, E2BSA failed
to obliterate completely the E2-induced massive release of
LH. Nevertheless, E2BSA decreased the magnitude of the
preovulatory surge of LH induced by E2, not only delaying
the onset of the surge of LH, but also resulting in an early
termination of the preovulatory-like surge of LH, and to
some extent reducing the amount of LH released. It is not
clear why the decrease in the amount of LH released by
E2BSA was more apparent in ewes highly responsive to E2
than in ewes with a lower responsiveness to E2. If as pro-
posed, E2BSA is reducing responsiveness of the pituitary
gland to GnRH, it is more likely that E2BSA could over-
ride the GnRH input during the beginning and the end of
the surge of LH, when secretion of GnRH is not at the
maximum concentration [1,4,8,16,17,19]. Notwithstand-
ing the expected increase in the number of GnRH recep-
tors, the net effect of E2BSA was a reduction in the
magnitude of the preovulatory-like surge of LH. This
implies a predominant role of the membrane-initiated
actions of E2 in the mediation of the negative feedback
effect on LH secretion compared with a minor contribu-
tion, by itself, on the synthesis of GnRH receptor. This
interpretation is consistent with the slight increase in the
number of GnRH receptors induced by E2BSA, compared
with that induced by E2, and agrees with other experi-
mental paradigms where equimolar doses of conjugated
or un-conjugated E2 induced a similar decrease in LH
secretion in ewes, [30] and in primary cultures of ovine
pituitary cells [13]; whereas in the same cells, higher
doses of E2BSA were required to increase the number of
GnRH receptors [39].
Although regulation of synthesis and/or secretion of
GnRH by E2BSA were not evaluated during the expected
time of the preovulatory-like surge of LH, we do not think
that the effects were mediated via the hypothalamus. In
support of this notion: a) E2BSA did not modulate the
pulsatile profile of GnRH (at least for the first 4 h after
administration), b) conjugated E2 was stable in blood (at
least for 24 h), and c) administration of a high dose of
E2BSA just before the preovulatory-like surge of LH
induced by E2 decreased the amount of LH released.
Therefore we suggest that the actions of E2BSA on LH
secretion are the result of a direct action on the pituitary
gland.
Conclusions
The rapid suppression of LH secretion induced by E2BSA
is mediated only via a direct action on the pituitary gland.
E2 acting via a membrane-initiated pathway contributes
to the E2-induced increase in the number of GnRH recep-
tors. Administration of E2BSA near the beginning of the
pre-ovulatory LH surge delays and reduces the magni-
tude of the surge.
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